The prevalence of concurrently raised blood glucose and blood pressure in India: a cross-sectional study of 2035 662 adults.


Journal

Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882

Informations de publication

Date de publication:
09 2019
Historique:
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 1 7 2020
Statut: ppublish

Résumé

To inform integrated, person-centered interventions, this study aimed to determine the prevalence of having both a raised blood glucose and blood pressure (BP) in India, and its variation among states and population groups. We pooled data from three large household surveys (the Annual Health Survey, District Level Household and Facility Survey, and National Family Health Survey), which were carried out between 2012 and 2016 and included adults aged at least 15 years. Raised blood glucose was defined as having a plasma glucose reading at least 126 mg/dl if fasted and at least 200 mg/dl if not fasted, and raised BP as a SBP of at least 140 mmHg or DBP of at least 90 mmHg. The prevalence of having a concurrently raised blood glucose and BP (comorbid) was age-standardized to India's national population structure, and disaggregated by sex, age group, BMI group, rural-urban residency, household wealth quintile, education, state, and region. The age-standardized prevalence of this comorbidity was 1.5% [95% confidence interval (CI), 1.5-1.5], and varied by a factor of 8.3 between states. Among those aged at least 50 years, 4.5% (95% CI, 4.3-4.7) with a BMI less than 23.0 kg/m and 16.1% (95% CI, 15.0-17.4) with a BMI at least 30 kg/m were comorbid. Age, BMI, household wealth quintile, male sex, and urban location were all positively associated with this comorbidity. A substantial proportion of India's population had both a raised blood glucose and BP, calling for integrated interventions to reduce cardiovascular disease risk. We identified large variation among states, age groups, and by rural-urban residency, which can inform health system planning and the targeting of interventions, such as appropriate screening programs, to those most in need.

Identifiants

pubmed: 31368919
doi: 10.1097/HJH.0000000000002114
pii: 00004872-201909000-00013
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1822-1831

Commentaires et corrections

Type : CommentIn

Auteurs

Anne C Bischops (AC)

Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.

Jennifer Manne-Goehler (J)

Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Lindsay M Jaacks (LM)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Public Health Foundation of India, New Delhi, Delhi NCR.

Ashish Awasthi (A)

Public Health Foundation of India, New Delhi, Delhi NCR.
Indian Institute of Public Health, Gandhinagar, Gujarat, India.

Michaela Theilmann (M)

Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Center for Evaluation and Development - C4ED, University of Mannheim, Mannheim, Germany.

Justine I Davies (JI)

MRC/Wits Rural Public Health and Health Transitions Research Unit, School of Public Health, Education Campus, University of Witwatersrand, Johannesburg, South Africa.
Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Rifat Atun (R)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts, USA.

Till Bärnighausen (T)

Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Africa Health Research Institute, Mtubatuba, South Africa.

Sebastian Vollmer (S)

Department of Economics & Centre for Modern Indian Studies, University of Goettingen, Göttingen, Germany.

Pascal Geldsetzer (P)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH